Preview

Lechaschi Vrach

Advanced search

The current state of the rosacea problem

https://doi.org/10.51793/OS.2022.25.6.005

Abstract

Rosacea is a chronic inflammatory disease with a prevalence of 0.5% to 18%. Rosacea is more common in people of northern and Western European origin, less common in other ethnic groups. According to some data, about 4% of rosacea patients are of African, Latin American or Asian origin. Women are found on average a third more than men. Rosacea usually manifests in patients aged 30-50 years. However, it can occur in childhood with a family history of rosacea, persist and progress into adulthood. Rosacea is chronic, can develop from erythema, telangiectasia to rhinophyma, and also cause eye damage. The classification of rosacea includes four subtypes and a variant of granulomatous rosacea. Adverse trigger factors of rosacea are endocrinological, pharmacological, immunological, infectious, climatic, thermal and alimentary factors. Skin with rosacea is most sensitive to temperature changes, especially to heat. Clinical trigger factors that contribute to rosacea outbreaks or disease progression are associated with increased stress of the endoplasmic reticulum, which indicates a birth defect predisposed rosacea patients to increased stress of the endoplasmic reticulum and pathologies associated with it. Numerous factors are involved in the pathogenesis of rosacea, such as impaired barrier function of the epidermis, inflammation mediated by cathelicidin antimicrobial peptide, vascular reactivity disorders, increased innate immunity, neurogenic inflammation, angiogenesis, fibrosis and hypercolonization of demodex mites. Rosacea requires an interdisciplinary approach consisting of adequate general measures, local and/or systemic therapy, physical methods for the targeted treatment of various symptoms. The choice of treatment method depends primarily on the severity of the disease and varies from avoiding factors that can provoke an exacerbation of the disease to the use of surgical intervention to correct hypertrophied soft tissues of the nose (rhinophymes). Prevention of factors provoking rosacea and proper skin care such as sunscreens and moisturizers are important steps in the treatment and prevention of rosacea patients.

About the Authors

K. V. Ayupova
Kazan State Medical Academy – branch of the Federal State Budgetary Educational Institution of Additional Professional Education Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
Россия

Kamila V. Ayupova, PhD student of the Department of Dermatovenerology and Cosmetology

eLibrary SPIN: 5743-6872

4 A Tolstoi str., Kazan, 420012



L. A. Yusupovа
Kazan State Medical Academy – branch of the Federal State Budgetary Educational Institution of Additional Professional Education Russian Medical Academy of Continuing Professional Education of the Ministry of Health of the Russian Federation
Россия

Luiza A. Yusupovа, Dr. of Sci. (Med.), Professor, Heasd of the Department of Dermatovenerology and Cosmetology

eLibrary SPIN: 5743-6872

4 A Tolstoi str., Kazan, 420012



References

1. Blount B. U., Pelletier A. L. Rosacea: A common but often overlooked condition // Am Pham is a Doctor. 2002; 66 (3): 435-440.

2. Powell F. C. Clinical practice. Rosacea // N Engl J Med. 2005; 352 (8): 793-803.

3. Tan J., Berg M. Rosacea: the current state of epidemiology // J Am Acad Dermatol. 2013; 69 (6 Suppl 1): 27–35. 10.1016/j.jaad.2013.04.043.

4. Buddenkotte J., Steinhoff M. Recent advances in the understanding and management of rosacea // F1000Res. 2018; 7: F1000 Rev-1885. DOI: 10.12688/f1000research.16537.

5. Oge' L. K., Muncie H. B., Phillips-Savoy A. R. Rosacea: Diagnosis and treatment // Am Pham Doctor. 2015; 92 (3): 187-196.

6. Powell F. C. Clinical practice // Rosacea. 2005; 352 (8): 793-803. 10.1056/NEJMcp042829.

7. Casas C., Paul C., Lahfa M. Quantitative assessment of Demodex folliculorum by PCR in rosacea and its connection with the activation of innate skin immunity // Exp Dermatol. 2012; 21 (12): 906-910. 10.1111/exd.12030.

8. Yusupova L. A. Level sL-selectin in blood serum of patients with schizophrenia comorbidity pyoderma // European Journal of Natural History. 2013; 3: 19-20. https://world-science.ru/en/article/view?id=33122.

9. Egeberg A., Hansen P. R., Gislason G. H. Rosacea patients have an increased risk of depression and anxiety disorders: A Danish nationwide cohort study // Dermatology. 2016; 232 (2): 208-213. 10.1159/000444082.

10. Bewley A., Fowler J., Schöfer H. Erythema rosacea worsens the quality of life associated with health: Results of a meta-analysis // Dermatol Ter (Heidelb). 2016; 6 (2): 237-247. 10.1007/s13555-016-0106-9.

11. Yusupova L. A. A modern view on the problem of skin aging // The Lechaschi Vrach Journal. 2017; 6: 75. https://www.lvrach.ru/2017/06/15436750.

12. Buhl T., Sulk M., Nowak P. The molecular and morphological characteristics of the inflammatory infiltrate in Rosacea Reveal the activation of the Th1/Th17 pathways // J Invest Dermatol. 2015; 135 (9): 2198-2208. 10.1038/jid.2015.141.

13. Yusupova L. A., Mingazetdinova N. I. The current state of the problem of dry skin // The Lechaschi Vrach Journal 2014; 5: 41. https://www.lvrach.ru/2014/05/15435953.

14. Kelhälä H. L., Palatsi R., Fyhrquist N. The IL-17/Th17 pathway is activated in acne // PLoS One. 2014; 9 (8): e105238. 10.1371/journal.pone.0105238.

15. Chang A. L. S., Raber I., Xu J. Assessment of the genetic basis of rosacea by genome-wide associative research // J Invest Dermatol. 2015; 135 (6): 1548-1555. 10.1038/jid.2015.53.

16. Wilkin J., Dahl M., Detmar M. Standard classification of rosacea: Report of the expert committee of the National Rosacea Society on the classification and staging of rosacea // J Am Acad Dermatol. 2002; 46 (4): 584-587.

17. Yusupova L. A. The current state of the problem of exfoliative dermatitis // The Lechaschi Vrach Journal. 2019; 11: 6-8. https://www.lvrach.ru/2019/11/15437424.

18. Del Rosso J. Q. The role of skin care and maintaining proper barrier function in the treatment of rosacea // Cosmetic Dermatol. 2007; 20 (8): 485-490.

19. Schaller M., Almeida L. M., Bewley A. Updating Rosacea Treatment: Recommendations of the Global ROSacea Consensus Expert Group (ROSCO) // Br J Dermatol. 2017; 176 (2): 465-471.

20. Reinholz M., Ruzicka T., Steinhoff M. The pathogenesis and clinical picture of rosacea as the key to symptom-oriented therapy // J Dtsch Dermatol Ges. 2016; 14 (6): 4-15. 10.1111/ddg.13139.

21. Schaller M., Schöfer H., Homey B. Current state: Systemic treatment of rosacea // J Dtsch Dermatol Ges. 2016; 14 (6): 29-37. 10.1111/ddg.13141.

22. Tanghetti E., Del Rosso J. Q., Thiboutot D. Consensus recommendations of the American Society of Acne and Rosacea for the treatment of rosacea, part 4: report on the state of physical modalities and devices // Kutis. 2014; 93 (2): 71-76.

23. Del Rosso J. Q., Thiboutot D., Gallo R. Consensus recommendations of the American Society of Acne and Rosacea for the treatment of rosacea, part 3: report on the state of systemic therapy // Kutis. 2014; 93 (1): 18-28.

24. Olts M., Chek J. Rosacea and its ocular manifestations // Optometry. 2011; 82 (2): 92-103.


Review

For citations:


Ayupova K.V., Yusupovа L.A. The current state of the rosacea problem. Lechaschi Vrach. 2022;(5-6):30-33. (In Russ.) https://doi.org/10.51793/OS.2022.25.6.005

Views: 242

JATS XML

ISSN 1560-5175 (Print)
ISSN 2687-1181 (Online)